Stephanie Parker
Seattle Cancer Care Alliance(US)Northwest Medical Specialties(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Ethics in Clinical Research, Nonmelanoma Skin Cancer Studies
Most-Cited Works
- → Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology(2016)169 cited
- → Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited(2018)40 cited
- → Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer(2021)4 cited
- → Abstract OT3-1-02: Phase II randomized study of combination immunotherapy with or without Polysaccharide Krestin (PSK®) concurrently with a HER2 ICD peptide-based vaccine and trastuzumab in patients with stage IV breast cancer(2012)2 cited
- → Vaccination targeting insulin-like growth factor binding protein-2 (IGFBP-2) in advanced ovarian cancer: Safety and immunogenicity.(2016)2 cited
- → Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer(2017)2 cited
- → Cis-Compound Mutations are Prevalent in Triple Negative Breast Cancer and Can Drive Tumor Progression(2016)1 cited
- → P1-13-04: Phase II Study of Topical Imiquimod and Abraxane for Treatment of Breast Cancer Cutaneous Metastases.(2011)1 cited
- → OT3-01-19: Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases.(2011)1 cited
- → Abstract NTOC-097: VACCINATION TARGETING INSULIN–LIKE GROWTH FACTOR BINDING PROTEIN–2 (IGFBP–2) IN ADVANCED OVARIAN CANCER: SAFETY, IMMUNOGENICITY, AND SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) COMPARISON(2017)